Breakthrough in Female Arousal Product
For over three decades, women have been waiting for a solution akin to Viagra. Now, the wait is over. Daré Bioscience has launched “DARE to PLAY”, an innovative topical cream hailed as a breakthrough in female sexual wellness.
Science-Driven Innovation
This remarkable product works in just 10 minutes and taps into the power of sildenafil, the same active ingredient found in Viagra. DARE to PLAY enhances blood flow, effectively improving sexual arousal—a challenge faced by over 20 million women. According to the CEO, Sabrina Martucci Johnson, it marks a significant advancement towards acknowledging women’s needs in the realm of sexual health.
Easy and Accessible Usage
The cream should be applied 10 to 15 minutes before intimacy, once daily, offering convenience and rapid results. It’s currently available by prescription in 10 states and will soon expand across the country. As insurance typically doesn’t cover compounded medications like DARE to PLAY, many turn to Flexible or Health Savings Accounts for payment.
The Scientific Assurance
Backed by extensive research, including peer-reviewed studies, the cream stands apart from other arousal products by adhering to manufacturing standards. While awaiting full FDA approval, its benefits are supported by comprehensive clinical trials, affirming its efficacy and safety.
Empowering Women Everywhere
Daré Bioscience claims this product as a long-awaited correction in sexual wellness for women, fostering confidence and self-reconnection. Available as a Section 503B compounded product, the cream offers quality assurance and paves the way for further recognition of women’s unique health demands. As stated in The Independent, this development is a major triumph for women’s health.
Join the conversation in our commenting forum and explore more about this exciting advancement in women’s empowerment and sexual health.
